Equibles does not estimate personal net worth.
Stuart Peltz was last confirmed as CEO and Board Member at Ptc Therapeutics, Inc. (PTCT) in a filing dated April 28, 2022. The proxy statement of Ptc Therapeutics, Inc. reports total compensation of $7,759,441 for Stuart Peltz in fiscal 2019, including a base salary of $702,000. Disclosed compensation is on record for 3 fiscal years. Stuart Peltz has spoken on 12 earnings calls across 1 company, most recently for Ptc Therapeutics, Inc. on January 9, 2023. The companies whose calls Stuart Peltz spoke on are classified in the Healthcare sector.
“I'm proud to share PTC's fourth quarter and full year results and our expectations for continued strong performance in 2023. PTC treats rare diseases by modulating gene and protein expression.”
“I'm pleased to share PTC’s strong third quarter results. We continue to demonstrate strong execution and are moving forward on our 2022 milestones.”
“I'm excited to share PTC's second quarter results for what I expect to be a transformational year for the company. Our mission at PTC is to discover and develop innovative therapies and bring them to patients with rare disorders and, in doing so, to create significant value for all of our stakeholders.”
“I'm excited to share PTC's first quarter results, but first, an update on what I expect to be a transformative year for the company. On this, PTC has developed therapeutics to help treat patients with rare disorders while producing revenue to provide value for all of our stakeholders.”
“I'm excited to share with you today the significant progress in 2021. Over the last two decades, we have advanced innovative therapies from ideas and discovery to commercializing and distributing them to patients around the globe.”
Start not stated–2022-04-28
Last confirmed by a filing; no departure on record
Start not stated–2022-04-28
Last confirmed by a filing; no departure on record
Biotechnology · Healthcare
CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Ptc Therapeutics, Inc. (PTCT) | Chief Executive Officer | $702,000 | $7,759,441 |
| 2018 | Ptc Therapeutics, Inc. (PTCT) | Chief Executive Officer | $658,819 | $4,016,735 |
| 2017 | Ptc Therapeutics, Inc. (PTCT) | Chief Executive Officer | $636,540 | $2,172,683 |
